Companies: 10,795·Total market cap: $144.5T
IRIDEX Corporation

IRIDEX Corporation

IRIXNASDAQHealthcare● Active
$1.12
+$0.01(+0.62%)
Market Cap$19441320
P/E Ratio
52W High$1.65
52W Low$0.87

IRIDEX Corporation (IRIX) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

IRIX · shares outstanding · updated Jun 9, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
17.2M +4.55% YoY Change
FY · as of Jan 3, 2026 · Reported in USD
vs 16.4M in FY 2024
Diluted Shares Outstanding
17.2M
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+4.55%
year-over-year
Float (Free Float)
11.4M
publicly tradable shares
65.4% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-09

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+2.5%
2022 → 2026
5-Year CAGRincreasing
+4.4%
2020 → 2026
10-Year CAGRincreasing
+5.6%
2015 → 2026

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2026Latest
Diluted Shares: 17.2M
17.2M
+4.55%
FY 2024
Diluted Shares: 16.4M
16.4M
+1.93%
FY 2023
Diluted Shares: 16.1M
16.1M
+1.19%
FY 2022
Diluted Shares: 15.9M
15.9M
+3.35%
FY 2021
Diluted Shares: 15.4M
15.4M
+11.41%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs IRIX
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+>999%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+>999%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+>999%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+>999%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+>999%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+>999%
#7
IRIDEX CorporationIRIX
IRIDEX CorporationYOU
17.2M

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

IRIDEX Corporation (IRIX) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of January 3, 2026, IRIDEX Corporation reports 17.2M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

IRIDEX Corporation's basic shares outstanding (17.2M) represents currently issued shares. Diluted shares outstanding (17.2M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

IRIDEX Corporation's float is 11.4M (65.4% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float11.4M(65.4%)
Outstanding17.4M

Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

IRIDEX Corporation (IRIX) shares outstanding history from 2006 to 2026. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

IRIDEX Corporation shares outstanding for the fiscal year ending January 3, 2026 were 17.2M, a 4.55% increase year-over-year. IRIDEX Corporation FY 2026 shares outstanding were 17.2M, a +4.55% increase from FY 2024.

IRIDEX Corporation is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +5.6% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.

Frequently asked questions

IRIX shares outstanding · 4 questions

As of January 3, 2026, IRIDEX Corporation (IRIX) has approximately 17.2M basic shares outstanding and 17.2M diluted shares outstanding. This represents a +4.55% year-over-year increase from FY 2024 (16.4M). The increase may reflect equity compensation issuances or secondary offerings.

IRIX shares outstandinghow many shares does IRIX haveIRIX basic shares 2026IRIX diluted shares

Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · IRIDEX Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-09